Publications by authors named "Eleonora Baldi"

Claim this Profile
T
The Diagnostic Utility of Oligoclonal Bands in Multiple Sclerosis: A Time-Course Analysis.
Raffaella Candeloro, Caterina Ferri, Michele Laudisi, Eleonora Baldi, Maura Pugliatti

Biomedicines· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study.
Jette Lautrup Frederiksen, Luca Massacesi, Helle Hvilsted Nielsen, Augusto Rini, Eleonora Baldi

Mult Scler Relat Disord· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.
Maria Pia Amato, Roberto Bergamaschi, Diego Centonze, Massimiliano Mirabella, Girolama Alessandra Marfia, Eleonora Baldi

J Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis.
Caterina Ferri, Massimiliano Castellazzi, Nicola Merli, Michele Laudisi, Elisa Baldin, Eleonora Baldi

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric recurrent acute necrotizing encephalomyelitis, RANBP2 genotype and Sars-CoV-2 infection: Diagnosis, pathogenesis and targeted treatments from a case study.
Cristina Forest, Michele Laudisi, Cristina Malaventura, Valeria Tugnoli, Giuditta Pellino, Eleonora Baldi

Eur J Paediatr Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein-Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study.
Massimiliano Castellazzi, Caterina Ferri, Alice Piola, Samantha Permunian, Gaia Buscemi, Eleonora Baldi

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS.
Keng-Shuo Pi, Daria Bortolotti, Yurou Sang, Giovanna Schiuma, Silvia Beltrami, Eleonora Baldi

Viruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trans-anal irrigation in patients with multiple sclerosis: Efficacy in treating disease-related bowel dysfunctions and impact on the gut microbiota: A monocentric prospective study.
Simona Ascanelli, Cristina Bombardini, Laura Chimisso, Paolo Carcoforo, Silvia Turroni, Eleonora Baldi

Mult Scler J Exp Transl Clin· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity.
Daria Bortolotti, Valentina Gentili, Alessandra Bortoluzzi, Marcello Govoni, Giovanna Schiuma, Eleonora Baldi

Microorganisms· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients.
Massimiliano Castellazzi, Giuseppe Lamberti, Maria Vittoria Resi, Eleonora Baldi, Luisa Maria Caniatti

Dis Markers· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.
Massimiliano Castellazzi, Andrea Morotti, Carmine Tamborino, Francesca Alessi, Silvy Pilotto, Eleonora Baldi

Fluids Barriers CNS· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis in Italy: A 40-Year Follow-Up of the Prevalence in Ferrara.
Enrico Granieri, Giulia De Mattia, Michele Laudisi, Vittorio Govoni, Massimiliano Castellazzi, Eleonora Baldi

Neuroepidemiology· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study.
Erica Curti, Elena Tsantes, Eleonora Baldi, Luisa Maria Caniatti, Diana Ferraro

Mult Scler Relat Disord· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence.
Diana Ferraro, Valentina Camera, Eleonora Baldi, Veria Vacchiano, Erica Curti

Curr Med Res Opin· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive childlessness in women with multiple sclerosis: a multicenter study.
Diana Ferraro, Anna Maria Simone, Giorgia Adani, Francesca Vitetta, Claudia Mauri, Eleonora Baldi

Neurol Sci· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.
Alessandro Trentini, Massimiliano Castellazzi, Arianna Romani, Monica Squerzanti, Eleonora Baldi

J Neurol Sci· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
Alessandro Trentini, Massimiliano Castellazzi, Carlo Cervellati, Maria Cristina Manfrinato, Carmine Tamborino, Eleonora Baldi

Dis Markers· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients.
Roberta Rizzo, Daria Bortolotti, Enrico Fainardi, Valentina Gentili, Silvia Bolzani, Eleonora Baldi

J Neuroimmunol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis.
Enrico Fainardi, Daria Bortolotti, Silvia Bolzani, Massimiliano Castellazzi, Carmine Tamborino, Eleonora Baldi

Mult Scler· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis.
Alessandro Trentini, Maria C Manfrinato, Massimiliano Castellazzi, Carmine Tamborino, Gloria Roversi, Eleonora Baldi

Mult Scler· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum ferroxidase activity in patients with multiple sclerosis: a pilot study.
Carlo Cervellati, Arianna Romani, Enrico Fainardi, Alessandro Trentini, Monica Squerzanti, Eleonora Baldi

In Vivo· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
Massimiliano Castellazzi, Carlo Contini, Carmine Tamborino, Francesca Fasolo, Gloria Roversi, Eleonora Baldi

J Neuroinflammation· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Eleonora Baldi, Angelica Guareschi, Francesca Vitetta, Caterina Senesi, Erica Curti

Curr Med Res Opin· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.
Fabio Morandi, Consuelo Venturi, Roberta Rizzo, Massimiliano Castellazzi, Eleonora Baldi

J Neuroimmune Pharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
Roberta Rizzo, Daria Bortolotti, Nadia Ben Fredj, Antonella Rotola, Francesca Cura, Eleonora Baldi

Hum Immunol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis